KIT 1 (Keep in Touch) Project-Televisits for Cancer Patients during Italian Lockdown for COVID-19 Pandemic: The Real-World Experience of Establishing a Telemedicine System.
digital health
radiation oncology
telemedicine
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
06 Jul 2023
06 Jul 2023
Historique:
received:
22
03
2023
revised:
09
06
2023
accepted:
30
06
2023
medline:
14
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
To evaluate the adoption of an integrated eHealth platform for televisit/monitoring/consultation during the COVID-19 pandemic. During the lockdown imposed by the Italian government during the COVID19 pandemic spread, a dedicated multi-professional working group was set up in the Radiation Oncology Department with the primary aim of reducing patients' exposure to COVID-19 by adopting de-centralized/remote consultation methodologies. Each patient's clinical history was screened before the visit to assess if a traditional clinical visit would be recommended or if a remote evaluation was to be preferred. Real world data (RWD) in the form of patient-reported outcomes (PROMs) and patient reported experiences (PREMs) were collected from patients who underwent televisit/teleconsultation through the eHealth platform. During the lockdown period (from 8 March to 4 May 2020) a total of 1956 visits were managed. A total of 983 (50.26%) of these visits were performed via email (to apply for and to upload of documents) and phone call management; 31 visits (1.58%) were performed using the eHealth system. Substantially, all patients found the eHealth platform useful and user-friendly, consistently indicating that this type of service would also be useful after the pandemic. The rapid implementation of an eHealth system was feasible and well-accepted by the patients during the pandemic. However, we believe that further evidence is to be generated to further support large-scale adoption.
Identifiants
pubmed: 37444784
pii: healthcare11131950
doi: 10.3390/healthcare11131950
pmc: PMC10340416
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Healthcare (Basel). 2021 Sep 26;9(10):
pubmed: 34682948
Science. 2020 May 8;368(6491):
pubmed: 32234805
J Bone Oncol. 2020 Apr 13;22:100291
pubmed: 32292693
Lancet Digit Health. 2020 Aug;2(8):e435-e440
pubmed: 32835201
Radiat Oncol. 2022 Apr 15;17(1):78
pubmed: 35428267
JAMA. 2020 Apr 14;323(14):1341-1342
pubmed: 32125371
J Coll Physicians Surg Pak. 2023 Mar;33(3):362-363
pubmed: 36945173
Dermatol Ther. 2022 Mar;35(3):e15276
pubmed: 34923731
Strahlenther Onkol. 2020 Dec;196(12):1094-1095
pubmed: 32945893
J Pers Med. 2022 Jun 24;12(7):
pubmed: 35887535
J Contemp Brachytherapy. 2019 Dec;11(6):510-515
pubmed: 31969908
Tech Innov Patient Support Radiat Oncol. 2022 Nov 01;24:101-106
pubmed: 36387778
Radiother Oncol. 2000 Mar;54(3):255-9
pubmed: 10738084
Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):435-437
pubmed: 32890527
Radiol Med. 2018 Apr;123(4):286-295
pubmed: 29230678
JAMA. 2020 Jul 28;324(4):337-338
pubmed: 32597963
JAMA. 2022 Jun 28;327(24):2413-2422
pubmed: 35661856
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1136-1139
pubmed: 32333832
Adv Radiat Oncol. 2020 Apr 01;5(4):659-665
pubmed: 32292839
Med Health Care Philos. 2021 Jun;24(2):247-253
pubmed: 33389365
J Contemp Brachytherapy. 2020 Apr;12(2):105-110
pubmed: 32395133
Ther Adv Gastrointest Endosc. 2022 Mar 16;15:26317745221081596
pubmed: 35342883
Radiother Oncol. 2020 May;146:223-229
pubmed: 32342863
J Pers Med. 2021 Apr 02;11(4):
pubmed: 33918214
J Med Internet Res. 2020 Mar 27;22(3):e16769
pubmed: 32217498
J Contemp Brachytherapy. 2020 Oct;12(5):497-500
pubmed: 33299440
Front Public Health. 2023 Jan 23;11:1056307
pubmed: 36755901
Prim Health Care Res Dev. 2018 Mar;19(2):151-164
pubmed: 28899449
Ann Intern Med. 2019 Aug 6;171(3):222-224
pubmed: 31035294
Cancer. 2023 Aug 1;129(15):2284-2289
pubmed: 37183438
Clin Infect Dis. 2018 Jul 18;67(3):388-397
pubmed: 29432526
Radiology. 2020 Aug;296(2):E65-E71
pubmed: 32191588
J Contemp Brachytherapy. 2018 Jun;10(3):260-266
pubmed: 30038647
Patient Educ Couns. 2021 Sep;104(9):2152-2153
pubmed: 33608213
J Thorac Oncol. 2019 Jun;14(6):1012-1020
pubmed: 30776447
Acta Oncol. 2013 Oct;52(7):1417-22
pubmed: 23957565
Diagnostics (Basel). 2021 Jan 05;11(1):
pubmed: 33466307
In Vivo. 2021 Jul-Aug;35(4):2313-2319
pubmed: 34182511
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28423407
AI Soc. 2020;35(3):761-765
pubmed: 32346223
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Breast Cancer. 2020 Mar;27(2):179-185
pubmed: 31452014
JAMA. 2013 Dec 11;310(22):2395-6
pubmed: 24158428
Tech Innov Patient Support Radiat Oncol. 2021 Jun;18:32-34
pubmed: 33969234
Front Oncol. 2020 Dec 03;10:595012
pubmed: 33344243
N Engl J Med. 2020 Jun 4;382(23):e82
pubmed: 32240581
J Contemp Brachytherapy. 2016 Aug;8(4):336-43
pubmed: 27648088
N Engl J Med. 2016 Jul 14;375(2):154-61
pubmed: 27410924
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):618-627
pubmed: 32302681
J Contemp Brachytherapy. 2020 Feb;12(1):84-89
pubmed: 32190074
JMIR Mhealth Uhealth. 2019 Jul 24;7(7):e12345
pubmed: 31342906
J Med Imaging Radiat Sci. 2022 Mar;53(1):58-64
pubmed: 35115275
J Contemp Brachytherapy. 2021 Dec;13(6):599-604
pubmed: 35079244
Clin Complement Med Pharmacol. 2022 Dec;2(4):100041
pubmed: 36377228
Eur J Surg Oncol. 2020 Jun;46(6):1194-1195
pubmed: 32376146
Radiother Oncol. 2020 Aug;149:73-77
pubmed: 32389752
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
Adv Radiat Oncol. 2020 Apr 28;5(4):690-696
pubmed: 32346656
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):765-774
pubmed: 29891200
J Pers Med. 2021 Jan 22;11(2):
pubmed: 33498985
Lancet Digit Health. 2023 Mar;5(3):e107-e108
pubmed: 36754724
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821
ESMO Open. 2020 Apr;5(2):
pubmed: 32295769
J Contemp Brachytherapy. 2017 Dec;9(6):540-547
pubmed: 29441098
Radiol Med. 2022 Mar;127(3):341-348
pubmed: 35092552
JNCI Cancer Spectr. 2023 Mar 1;7(2):
pubmed: 36929393
Artif Intell Med. 2019 May;96:145-153
pubmed: 30292538
Ann Ist Super Sanita. 2021 Jan-Mar;57(1):1-6
pubmed: 33797398
JCO Glob Oncol. 2020 Sep;6:1455-1460
pubmed: 32997540
Eur Rev Med Pharmacol Sci. 2022 Apr;26(8):2891-2899
pubmed: 35503635
Med Oncol. 2012 Dec;29(5):3478-83
pubmed: 22674154
N Engl J Med. 2015 Apr 30;372(18):1684-5
pubmed: 25923547
Int J Gynecol Cancer. 2022 Feb;32(2):127-132
pubmed: 34903559
J Cancer Res Clin Oncol. 2020 Oct;146(10):2535-2545
pubmed: 32656663
Adv Radiat Oncol. 2020 May 08;5(4):780-782
pubmed: 32391444
Radiol Med. 2019 Feb;124(2):145-153
pubmed: 30374650
Phys Med. 2021 Feb;82:7-16
pubmed: 33508633
Adv Radiat Oncol. 2020 Apr 01;5(4):582-588
pubmed: 32292842
Radiat Oncol. 2020 Sep 29;15(1):226
pubmed: 32993690
Adv Radiat Oncol. 2023 Jan-Feb;8(1):100924
pubmed: 36532603
Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):411-415
pubmed: 32890523
Ann Oncol. 2015 May;26(5):928-935
pubmed: 25609247
JCO Clin Cancer Inform. 2018 Dec;2:1-12
pubmed: 30652581
J Pers Med. 2021 Apr 19;11(4):
pubmed: 33921621